Balanced news tone
News Sentiment
002620 sentiment intelligence
Jeil Pharma Holdings Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
50
Balanced news tone
4 relevant articles
News tone and price action are not far from neutral.
80/100 classification confidence.
directly relevant articles
high-authority source matches
-0.4% over one week, -6.6% over four weeks, trend inactive, and below fair value.
Price to book forward of JEIL PHARMA HOLDINGS INC. – KRX:002620
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Primary event
Market update
80/100 classification
One-week reaction
-0.4%
Price digesting
Trend fit
Trend inactive
-6.6% over four weeks
Fair value
-26.1%
Below fair value
Value support
Sentiment Mix
Positive, neutral, negative
Positive
0
Neutral
4
Negative
0
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
TradingView
Direct company coverage
Price to book forward of JEIL PHARMA HOLDINGS INC. – KRX:002620
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 02:47
- Source
- TradingView
TradingView
Direct company coverage
Number of shareholders of JEIL PHARMA HOLDINGS INC. – KRX:002620
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 13 Jul 2026 01:27
- Source
- TradingView
Chosunbiz
Direct company coverage
Han Sang-cheol becomes co-CEO of JEIL PHARMACEUTICAL alongside Seong Seok-je - CHOSUNBIZ
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 Mar 2025 07:00
- Source
- Chosunbiz
koreabiomed.com
Direct company coverage
Viatris, Jeil Pharma to launch dyslipidemia compound in May
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 27 Apr 2021 07:00
- Source
- koreabiomed.com